The US Department of Justice recently announced that pharmaceutical company Biogen, Inc. (Biogen), agreed to pay $22 million to settle charges filed through the federal False Claims Act. The company,Read MorePharmaceutical Company Agrees To Pay $22 Million To Resolve Alleged False Claims Act and Anti-Kickback Statute Charges
